Nanomedicine in COVID-19

Nanomedicine in COVID-19 impacts all fields of medicine, and has been considered an important instrument for novel diagnostics, medical imaging, nanotherapeutics, vaccines and to develop biomaterials for regenerative medicine. Soft nanomaterials obtained from polymers, lipids, surfactants and proteins have been applied in nanomedicine, especially for drug delivery. The magnitude of interactions between nanomaterials and tissues  is the base for their use for various medical applications. The main limitations of antivirals are the lack of specific targeting, resulting in cytotoxicity of the host cell, which can be addressed by organic nanoparticles.

  • Biomaterials
  • Drug delivery
  • Soft nanomaterials
  • Nanomaterials
  • Nanoscale

Related Conference of Nanomedicine in COVID-19

May 30-31, 2024

9th Annual Conference and Expo on Biomaterials

Vienna, Austria

Nanomedicine in COVID-19 Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in